High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission

Ignazio Majolino, Marco Ladetto, Anna Locasciulli, Daniela Drandi, Fabio Benedetti, Andrea Gallamini, Teodoro Chisesi, Angelo De Blasio, Mario Boccadoro, Corrado Tarella

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Fingerprint

Entra nei temi di ricerca di 'High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission'. Insieme formano una fingerprint unica.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology